{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Severe hypertriglyceridaemia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_gemfibrozil",
          "name": "Gemfibrozil"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_niacin",
          "name": "Niacin"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_atorvastatin",
          "name": "Atorvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_simvastatin",
          "name": "Simvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_ezetimibe",
          "name": "Ezetimibe"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_lomitapide",
          "name": "Lomitapide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_mipomersen",
          "name": "Mipomersen"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_barricade",
          "name": "Barricade"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_alirocumab",
          "name": "Alirocumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_cevostamab",
          "name": "Cevostamab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 2
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_fenofibrate",
          "type": "Drug",
          "label": "Fenofibrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_gemfibrozil",
          "type": "Drug",
          "label": "Gemfibrozil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_niacin",
          "type": "Drug",
          "label": "Niacin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_atorvastatin",
          "type": "Drug",
          "label": "Atorvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_simvastatin",
          "type": "Drug",
          "label": "Simvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ezetimibe",
          "type": "Drug",
          "label": "Ezetimibe",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_omega_3_fatty_acids",
          "type": "Drug",
          "label": "Omega-3 fatty acids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lomitapide",
          "type": "Drug",
          "label": "Lomitapide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mipomersen",
          "type": "Drug",
          "label": "Mipomersen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_barricade",
          "type": "Drug",
          "label": "Barricade",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_alirocumab",
          "type": "Drug",
          "label": "Alirocumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cevostamab",
          "type": "Drug",
          "label": "Cevostamab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_lipid_metabolism",
          "type": "Target",
          "label": "Lipid Metabolism",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_lipid_regulation",
          "type": "Pathway",
          "label": "Lipid Regulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_severe_hypertriglyceridaemia",
          "type": "Disease",
          "label": "Severe Hypertriglyceridaemia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_fenofibrate",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Fenofibrate常用于调节脂代谢"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Gemfibrozil具有明显的脂质调节作用"
        },
        {
          "source": "drug_niacin",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Niacin已知影响脂质水平"
        },
        {
          "source": "drug_atorvastatin",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Atorvastatin有效降低血液脂肪"
        },
        {
          "source": "drug_simvastatin",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Simvastatin对脂肪代谢有影响"
        },
        {
          "source": "drug_ezetimibe",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Ezetimibe通过抑制胆固醇吸收调节脂质"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Omega-3脂肪酸可降低甘油三酯"
        },
        {
          "source": "drug_lomitapide",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Lomitapide用于特定脂质紊乱"
        },
        {
          "source": "drug_mipomersen",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Mipomersen针对特定脂质代谢问题"
        },
        {
          "source": "drug_barricade",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Barricade也与脂质过程相关"
        },
        {
          "source": "drug_alirocumab",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Alirocumab用于LDL调节，因此关联"
        },
        {
          "source": "drug_cevostamab",
          "target": "target_lipid_metabolism",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Cevostamab与脂质代谢潜在关联"
        },
        {
          "source": "target_lipid_metabolism",
          "target": "pathway_lipid_regulation",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "脂质代谢与调控通路密切关联"
        },
        {
          "source": "pathway_lipid_regulation",
          "target": "disease_severe_hypertriglyceridaemia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "脂质调控影响甘油三酯水平"
        },
        {
          "source": "drug_fenofibrate",
          "target": "H1",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Fenofibrate对严重高甘油三酯血症的有效性"
        },
        {
          "source": "drug_gemfibrozil",
          "target": "H2",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Gemfibrozil用于管理高甘油三酯水平"
        },
        {
          "source": "drug_niacin",
          "target": "H3",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Niacin已证明降低甘油三酯"
        },
        {
          "source": "drug_atorvastatin",
          "target": "H4",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Atorvastatin用于高脂血症"
        },
        {
          "source": "drug_simvastatin",
          "target": "H5",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Simvastatin作为降脂药物有效"
        },
        {
          "source": "drug_ezetimibe",
          "target": "H6",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Ezetimibe调节胆固醇吸收"
        },
        {
          "source": "drug_omega_3_fatty_acids",
          "target": "H7",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Omega-3降低甘油三酯常识"
        },
        {
          "source": "drug_lomitapide",
          "target": "H8",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Lomitapide用于特定高甘油三酯状况"
        },
        {
          "source": "drug_mipomersen",
          "target": "H9",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Mipomersen在管理高脂血症中应用"
        },
        {
          "source": "drug_barricade",
          "target": "H10",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Barricade在脂质调节方面的潜力"
        },
        {
          "source": "drug_alirocumab",
          "target": "H11",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Alirocumab对脂质调节的作用"
        },
        {
          "source": "drug_cevostamab",
          "target": "H12",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Cevostamab与脂质代谢有潜在联系"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过影响脂代谢途径支持管理严重高甘油三酯血症",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物具备到达靶器官的最小暴露（常识判断）"
    ],
    "uncertainties": [],
    "next_focus_for_pi": [
      "是否需要进一步的文献支持以增强特定药物的强化证据？"
    ]
  }
}